{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T23:39:21Z","timestamp":1775173161214,"version":"3.50.1"},"reference-count":70,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Exp Hematopathol","JCEH"],"published-print":{"date-parts":[[2014]]},"DOI":"10.3960\/jslrt.54.11","type":"journal-article","created":{"date-parts":[[2014,6,17]],"date-time":"2014-06-17T23:13:54Z","timestamp":1403046834000},"page":"11-22","source":"Crossref","is-referenced-by-count":10,"title":["Pathology of Indolent B-Cell Neoplasms Other than Follicular Lymphoma"],"prefix":"10.3960","volume":"54","author":[{"given":"Seiji","family":"Sakata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoko","family":"Tsuyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kengo","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2349","reference":[{"key":"1","unstructured":"1 Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, <I>et al<\/I>.: WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues. IARC Press: Lyon, 2008"},{"key":"2","unstructured":"2 Dores GM, Anderson WF, Curtis RE, Landgren O, Ostroumova E, <I>et al<\/I>.: Chronic lymphocytic leukaemia and small lymphocytic lymphoma: overview of the descriptive epidemiology. Br J Haematol 139:809-819, 2007"},{"key":"3","unstructured":"3 Ben-Ezra J, Burke JS, Swartz WG, Brownell MD, Brynes RK, <I>et al<\/I>.: Small lymphocytic lymphoma: a clinicopathologic analysis of 268 cases. Blood 73:579-587, 1989"},{"key":"4","unstructured":"4 Rozman C, Montserrat E, Rodr&#237;guez-Fern&aacute;ndez JM, Ayats R, Vallesp&#237; T, <I>et al<\/I>.: Bone marrow histologic pattern - the best single prognostic parameter in chronic lymphocytic leukemia: a multivariate survival analysis of 329 cases. Blood 64:642-648, 1984"},{"key":"5","unstructured":"5 Zengin N, Kars A, Sungur A, Zengin NI, Hayran M, <I>et al<\/I>.: The significance of the bone marrow biopsy pattern in chronic lymphocytic leukemia: a prognostic dilemma. Am J Hematol 62:208-211, 1999"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Frater JL, McCarron KF, Hammel JP, Shapiro JL, Miller ML, <I>et al<\/I>.: Typical and atypical chronic lymphocytic leukemia differ clinically and immunophenotypically. Am J Clin Pathol 116:655-664, 2001","DOI":"10.1309\/7Q1J-1AA8-DU4Q-PVLQ"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Ho AK, Hill S, Preobrazhensky SN, Miller ME, Chen Z, <I>et al<\/I>.: Small B-cell neoplasms with typical mantle cell lymphoma immunophenotypes often include chronic lymphocytic leukemias. Am J Clin Pathol 131:27-32, 2009","DOI":"10.1309\/AJCPPAG4VR4IPGHZ"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Tandon B, Peterson L, Gao J, Nelson B, Ma S, <I>et al<\/I>.: Nuclear overexpression of lymphoid-enhancer-binding factor 1 identifies chronic lymphocytic leukemia\/small lymphocytic lymphoma in small B-cell lymphomas. Mod Pathol 24:1433-1443, 2011","DOI":"10.1038\/modpathol.2011.103"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Ek S, Dictor M, Jerkeman M, Jirstr&ouml;m K, Borrebaeck CA: Nuclear expression of the non B-cell lineage Sox 11 transcription factor identifies mantle cell lymphoma. Blood 111:800-805, 2008","DOI":"10.1182\/blood-2007-06-093401"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Tsimberidou AM, Keating MJ: Richter syndrome: biology, incidence, and therapeutic strategies. Cancer 103:216-228, 2005","DOI":"10.1002\/cncr.20773"},{"key":"11","unstructured":"11 Mao Z, Quintanilla-Martinez L, Raffeld M, Richter M, Krugmann J, <I>et al<\/I>.: IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution. Am J Surg Pathol 31:1605-1614, 2007"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Brecher M, Banks PM: Hodgkin's disease variant of Richter's syndrome. Report of eight cases. Am J Clin Pathol 93:333-339, 1990","DOI":"10.1093\/ajcp\/93.3.333"},{"key":"13","unstructured":"13 Tsimberidou AM, O'Brien S, Kantarjian HM, Kolle C, Hagemeister FB, <I>et al<\/I>.: Hodgkin transformation of chronic lymphocytic leukemia: the M. D. Anderson Cancer Center experience. Cancer 107:1294-1302, 2006"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Damle RN, Wasil T, Fais F, Ghiotto F, Valetto A, <I>et al<\/I>.: IgV gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 94:1840-1847, 1999","DOI":"10.1182\/blood.V94.6.1840.418k06_1840_1847"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK: Unmutated IgV (H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 94:1848-1854, 1999","DOI":"10.1182\/blood.V94.6.1848.418k05_1848_1854"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Ibrahim S, Keating M, Do KA, O'Brien S, Huh YO: CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia. Blood 98:181-186, 2001","DOI":"10.1182\/blood.V98.1.181"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Wiestner A, Rosenwald A, Barry TS, Wright G, Davis RE, <I>et al<\/I>.: ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. Blood 101:4944-4951, 2003","DOI":"10.1182\/blood-2002-10-3306"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Crespo M, Bosch F, Villamor N, Bellosillo B, Colomer D, <I>et al<\/I>.: ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. N Engl J Med 348:1764-1775, 2003","DOI":"10.1056\/NEJMoa023143"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Rassenti LZ, Huynh L, Toy TL, Chen L, Keating MJ, <I>et al<\/I>.: ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. N Engl J Med 351:893-901, 2004","DOI":"10.1056\/NEJMoa040857"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Montserrat E: New prognostic markers in CLL. Hematology Am Soc Hematol Educ Program 279-284, 2006","DOI":"10.1182\/asheducation-2006.1.279"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 D&ouml;hner H, Stilgenbauer S, Benner A, Leupolt E, Kr&ouml;ber A, <I>et al<\/I>.: Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 343:1910-1916, 2000","DOI":"10.1056\/NEJM200012283432602"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Tobin G, Thunberg U, Johnson A, Th&ouml;rn I, S&ouml;derberg O, <I>et al<\/I>.: Somatically mutated IgV(H) 3-21 genes characterize a new subset of chronic lymphocytic leukemia. Blood 99:2262-2264, 2002","DOI":"10.1182\/blood.V99.6.2262"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Thors&eacute;lius M, Kr&ouml;ber A, Murray F, Thunberg U, Tobin G, <I>et al<\/I>.: Strikingly homologous immunoglobulin gene rearrangements and poor outcome in VH3-21-using chronic lymphocytic leukemia patients independent of geographic origin and mutational status. Blood 107:2889-2894, 2006","DOI":"10.1182\/blood-2005-06-2227"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Schmid C, Kirkham N, Diss T, Isaacson PG: Splenic marginal zone cell lymphoma. Am J Surg Pathol 16:455-466, 1992","DOI":"10.1097\/00000478-199205000-00004"},{"key":"25","unstructured":"25 Berger F, Felman P, Thieblemont C, Pradier T, Baseggio L, <I>et al<\/I>.: Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients. Blood 95:1950-1956, 2000"},{"key":"26","unstructured":"26 Mollejo M, Men&aacute;rguez J, Lloret E, S&aacute;nchez A, Campo E, <I>et al<\/I>.: Splenic marginal zone lymphoma: a distinctive type of low-grade B-cell lymphoma. A clinicopathological study of 13 cases. Am J Surg Pathol 19:1146-1157, 1995"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Franco V, Florena AM, Campesi G: Intrasinusoidal bone marrow infiltration: a possible hallmark of splenic lymphoma. Histopathology 29:571-575, 1996","DOI":"10.1046\/j.1365-2559.1996.d01-536.x"},{"key":"28","unstructured":"28 Labouyrie E, Marit G, Vial JP, Lacombe F, Fialon P, <I>et al<\/I>.: Intrasinusoidal bone marrow involvement by splenic lymphoma with villous lymphocytes: a helpful immunohistologic feature. Mod Pathol 10:1015-1020, 1997"},{"key":"29","unstructured":"29 Melo JV, Robinson DS, Gregory C, Catovsky D: Splenic B cell lymphoma with &ldquo;villous&rdquo; lymphocytes in the peripheral blood: a disorder distinct from hairy cell leukemia. Leukemia 1:294-298, 1987"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Matutes E, Morilla R, Owusu-Ankomah K, Houlihan A, Catovsky D: The immunophenotype of splenic lymphoma with villous lymphocytes and its relevance to the differential diagnosis with other B-cell disorders. Blood 83:1558-1562, 1994","DOI":"10.1182\/blood.V83.6.1558.1558"},{"key":"31","unstructured":"31 Catovsky D, Matutes E: Splenic lymphoma with circulating villous lymphocytes\/splenic marginal-zone lymphoma. Semin Hematol 36:148-154, 1999"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Mollejo M, Lloret E, Men&aacute;rguez J, Piris MA, Isaacson PG: Lymph node involvement by splenic marginal zone lymphoma: morphological and immunohistochemical features. Am J Surg Pathol 21:772-780, 1997","DOI":"10.1097\/00000478-199707000-00005"},{"key":"33","unstructured":"33 Rossi D, Trifonov V, Fangazio M, Bruscaggin A, Rasi S, <I>et al<\/I>.: The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development. J Exp Med 209:1537-1551, 2012"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Kiel MJ, Velusamy T, Betz BL, Zhao L, Weigelin HG, <I>et al<\/I>.: Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma. J Exp Med 209:1553-1565, 2012","DOI":"10.1084\/jem.20120910"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Wanko SO, de Castro C: Hairy cell leukemia: an elusive but treatable disease. Oncologist 11:780-789, 2006","DOI":"10.1634\/theoncologist.11-7-780"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36 Hakimian D, Tallman MS, Hogan DK, Rademaker AW, Rose E, <I>et al<\/I>.: Prospective evaluation of internal adenopathy in a cohort of 43 patients with hairy cell leukemia. J Clin Oncol 12:268-272, 1994","DOI":"10.1200\/JCO.1994.12.2.268"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37 Bouroncle BA: Leukemic reticuloendotheliosis (hairy cell leukemia). Blood 53:412-436, 1979","DOI":"10.1182\/blood.V53.3.412.bloodjournal533412"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38 Went PT, Zimpfer A, Pehrs AC, Sabattini E, Pileri SA, <I>et al<\/I>.: High specificity of combined TRAP and DBA. 44 expression for hairy cell leukemia. Am J Surg Pathol 29:474-478, 2005","DOI":"10.1097\/01.pas.0000155152.56736.06"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39 Falini B, Tiacci E, Liso A, Basso K, Sabattini E, <I>et al<\/I>.: Simple diagnostic assay for hairy cell leukaemia by immunocytochemical detection of annexin A1 (ANXA1). Lancet 363:1869-1870, 2004","DOI":"10.1016\/S0140-6736(04)16356-3"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40 J&ouml;hrens K, Stein H, Anagnostopoulos I: T-bet transcription factor detection facilitates the diagnosis of minimal hairy cell leukemia infiltrates in bone marrow trephines. Am J Surg Pathol 31:1181-1185, 2007.","DOI":"10.1097\/PAS.0b013e318031045b"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41 Jasionowski TM, Hartung L, Greenwood JH, Perkins SL, Bahler DW: Analysis of CD10<SUP>+<\/SUP> hairy cell leukemia. Am J Clin Pathol 120:228-235, 2003","DOI":"10.1309\/QVJD31TEG9UJ18BQ"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42 Chen YH, Tallman MS, Goolsby C, Peterson L: Immunophenotypic variations in hairy cell leukemia. Am J Clin Pathol 125:251-259, 2006","DOI":"10.1309\/PMQXVY619Q8Y43AR"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43 Tiacci E, Trifonov V, Schiavoni G, Holmes A, Kern W, <I>et al<\/I>.: BRAF mutations in hairy-cell leukemia. N Engl J Med 364:2305-2315, 2011","DOI":"10.1056\/NEJMoa1014209"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44 Arcaini L, Zibellini S, Boveri E, Riboni R, Rattotti S, <I>et al<\/I>.: The BRAF V600E mutation in hairy cell leukemia and other mature B-cell neoplasms. Blood 119:188-191, 2012","DOI":"10.1182\/blood-2011-08-368209"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45 Laurini JA, Aoun P, Iqbal J, Chan W, Greiner TC: Investigation of the BRAF V600E mutation by pyrosequencing in lymphoproliferative disorders. Am J Clin Pathol 138:877-883, 2012","DOI":"10.1309\/AJCP5TWORA0TMXGL"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46 Owen RG: Developing diagnostic criteria in Waldenstrom's macroglobulinemia. Semin Oncol 30:196-200, 2003","DOI":"10.1053\/sonc.2003.50069"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47 Fonseca R, Hayman S: Waldenstr&ouml;m macroglobulinaemia. Br J Haematol 138:700-720, 2007","DOI":"10.1111\/j.1365-2141.2007.06724.x"},{"key":"48","unstructured":"48 Owen RG, Treon SP, Al-Katib A, Fonseca R, Greipp PR, <I>et al<\/I>.: Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia. Semin Oncol 30:110-115, 2003"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49 Treon SP, Xu L, Yang G, Zhou Y, Liu X, <I>et al<\/I>.: MYD88 L265P somatic mutation in Waldenstr&ouml;m's macroglobulinemia. N Engl J Med 367:826-833, 2012","DOI":"10.1056\/NEJMoa1200710"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50 Varettoni M, Arcaini L, Zibellini S, Boveri E, Rattotti S, <I>et al<\/I>.: Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom's macroglobulinemia and related lymphoid neoplasms. Blood 121:2522-2528, 2013","DOI":"10.1182\/blood-2012-09-457101"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51 Poulain S, Roumier C, Decambron A, Renneville A, Herbaux C, <I>et al<\/I>.: MYD88 L265P mutation in Waldenstrom macroglobulinemia. Blood 121:4504-4511, 2013","DOI":"10.1182\/blood-2012-06-436329"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52 Ansell SM, Secreto FJ, Manske M, Braggio E, Hodge LS, <I>et al<\/I>.: MYD88 pathway activation in lymphoplasmacytic lymphoma drives tumor cell growth and cytokine expression. Blood (ASH Annual Meeting Abstracts) 120:Abstract 2699, 2012 (<I>Abstract<\/I>)","DOI":"10.1182\/blood.V120.21.2699.2699"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53 Radaszkiewicz T, Dragosics B, Bauer P: Gastrointestinal malignant lymphomas of the mucosa-associated lymphoid tissue: factors relevant to prognosis. Gastroenterology 102:1628-1638, 1992","DOI":"10.1016\/0016-5085(92)91723-H"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54 Doglioni C, Wotherspoon AC, Moschini A, De Boni M, Isaacson PG: High incidence of primary gastric lymphoma in northeastern Italy. Lancet 339:834-835, 1992","DOI":"10.1016\/0140-6736(92)90280-G"},{"key":"55","unstructured":"55 Thieblemont C, Bastion Y, Berger F, Rieux C, Salles G, <I>et al<\/I>.: Mucosa-associated lymphoid tissue gastrointestinal and nongastrointestinal lymphoma behavior: analysis of 108 patients. J Clin Oncol 15:1624-1630, 1997"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56 Thieblemont C, Berger F, Dumontet C, Moullet I, Bouafia F, <I>et al<\/I>.: Mucosaassociated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed. Blood 95:802-806, 2000","DOI":"10.1182\/blood.V95.3.802.003k19_802_806"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57 W&ouml;hrer S, Streubel B, Bartsch R, Chott A, Raderer M: Monoclonal immunoglobulin production is a frequent event in patients with mucosa-associated lymphoid tissue lymphoma. Clin Cancer Res 10:7179-7181, 2004","DOI":"10.1158\/1078-0432.CCR-04-0803"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58 Streubel B, Huber D, W&ouml;hrer S, Chott A, Raderer M: Frequency of chromosomal aberrations involving MALT1 in mucosa-associated lymphoid tissue lymphoma in patients with Sj&ouml;gren's syndrome. Clin Cancer Res 10:476-480, 2004.","DOI":"10.1158\/1078-0432.CCR-0873-03"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59 Remstein ED, Dogan A, Einerson RR, Paternoster SF, Fink SR, <I>et al<\/I>.: The incidence and anatomic site specificity of chromosomal translocations in primary extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) in North America. Am J Surg Pathol 30:1546-1553, 2006","DOI":"10.1097\/01.pas.0000213275.60962.2a"},{"key":"60","unstructured":"60 Arcaini L, Paulli M, Burcheri S, Rossi A, Spina M, <I>et al<\/I>.: Primary nodal marginal zone B-cell lymphoma: clinical features and prognostic assessment of a rare disease. Br J Haematol 136:301-304, 2007"},{"key":"61","unstructured":"61 Nathwani BN, Anderson JR, Armitage JO, Cavalli F, Diebold J, <I>et al<\/I>.: Marginal zone B-cell lymphoma: A clinical comparison of nodal and mucosa-associated lymphoid tissue types. Non-Hodgkin's Lymphoma Classification Project. J Clin Oncol 17:2486-2492, 1999"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62 Arcaini L, Lucioni M, Boveri E, Paulli M: Nodal marginal zone lymphoma: current knowledge and future directions of an heterogeneous disease. Eur J Haematol 83:165-174, 2009","DOI":"10.1111\/j.1600-0609.2009.01301.x"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63 Traverse-Glehen A, Felman P, Callet-Bauchu E, Gazzo S, Baseggio L, <I>et al<\/I>.: A clinicopathological study of nodal marginal zone B-cell lymphoma. A report on 21 cases. Histopathology 48:162-173, 2006","DOI":"10.1111\/j.1365-2559.2005.02309.x"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64 Rodriguez Pinilla SM, Roncador G, Rodriguez-Peralto JL, Mollejo M, Garcia JF, <I>et al<\/I>.: Primary cutaneous CD4<SUP>+<\/SUP> small\/medium-sized pleomorphic T-cell lymphoma expresses follicular T-cell markers. Am J Surg Pathol 33:81-90, 2009","DOI":"10.1097\/PAS.0b013e31818e52fe"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65 Campo E, Miquel R, Krenacs L, Sorbara L, Raffeld M, <I>et al<\/I>.: Primary nodal marginal zone lymphomas of splenic and MALT type. Am J Surg Pathol 23:59-68, 1999","DOI":"10.1097\/00000478-199901000-00006"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66 Takeuchi K, Sakata S, Asaka R, Tsuyama N, Dobashi A, <I>et al<\/I>.: A low-grade B-cell lymphoma with prolymphocytic\/paraimmunoblastic proliferation and IRF4 rearrangement. Haematologica 98:e32-35, 2013","DOI":"10.3324\/haematol.2012.076851"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67 Iida S, Rao PH, Butler M, Corradini P, Boccadoro M, <I>et al<\/I>.: Deregulation of MUM1\/IRF4 by chromosomal translocation in multiple myeloma. Nat Genet 17:226-230, 1997","DOI":"10.1038\/ng1097-226"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68 Salaverria I, Philipp C, Oschlies I, Kohler CW, Kreuz M, <I>et al<\/I>.: Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults. Blood 118:139-147, 2011","DOI":"10.1182\/blood-2011-01-330795"},{"key":"69","doi-asserted-by":"crossref","unstructured":"69 Lennert K, Feller AC: Histopathology of Non-Hodgkin's Lymphomas (Based on Updated Kiel Classification). 2nd ed. New York: Springer-Verlag, pp.54-60, 1992","DOI":"10.1007\/978-3-642-97187-7_2"},{"key":"70","unstructured":"70 Lennert K: Malignant lymphomas. Berlin: Springer-Verlag, 1978"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T16:21:35Z","timestamp":1649434895000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/54\/1\/54_11\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.54.11","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}